Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 29 Sep 20 424B4 Prospectus supplement with pricing info
- 29 Sep 20 EFFECT Notice of effectiveness
- 28 Sep 20 F-1/A Registration statement (foreign) (amended)
- 25 Sep 20 FWP Free writing prospectus
- 25 Sep 20 F-1/A Registration statement (foreign) (amended)
- 25 Sep 20 FWP Free writing prospectus
- 24 Sep 20 F-1/A Registration statement (foreign) (amended)
- 23 Sep 20 FWP Free writing prospectus
- 23 Sep 20 F-1/A Registration statement (foreign) (amended)
- 21 Sep 20 F-1/A Registration statement (foreign) (amended)
-
4 Sep 20 F-1 Registration statement (foreign)
ORPHY similar filings
Filing view
External links
Exhibit 99.1
CONSENT OF PERSON TO BE NAMED DIRECTOR
As required by Rule 438 under the Securities Act of 1933, as amended, the undersigned consents to being named in the Registration Statement on Form F-1 (together with any amendments or supplements thereto, the “Registration Statement”) of Orphazyme A/S, a public limited liability company (Aktieselskab) organized and existing under the laws of Denmark (the “Company”), as a person who has agreed to serve as a director of the Company, and to the inclusion of his or her biographical information in the Registration Statement.
/s/ Carrolee Barlow |
Signature |
Carrolee Barlow |
Name |
August 13, 2020 |
Date |